Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P1.13-21 Clinical Efficacy and Safety of Apatinib Combined With EGFR - TKIs in Advanced Non-Small Cell Lung Cancer With EGFR - TKIs Resistance

Journal of Thoracic Oncology

English

Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial

Journal of Thoracic Oncology

English

P1.12-16 Management of Elderly Small-Cell Lung Cancer Patients in a Romanian Tertiary Care Center

Journal of Thoracic Oncology

English

P3.07-07 Multidisciplinary Supportive Care Assessment in Lung Cancer – A Case Study Example

Journal of Thoracic Oncology

English

P2.01-44 Prognostic Value of TP53 Hot Exon Mutation in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

Identification of a Novel MET Exon 14 Skipping Variant Coexistent With EGFR Mutation in Lung Adenocarcinoma Sensitive to Combined Treatment With Afatinib and Crizotinib

Journal of Thoracic Oncology

English

MS24.02 Legal Action Against the Tobacco Industry in Europe

Journal of Thoracic Oncology

English

P2.01-37 a Ph 1/2 Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) With Docetaxel in PTS With Previously Treated NSCLC

Journal of Thoracic Oncology

English

P2.01-101 Dynamic Monitoring of Gene Alterations With ctDNA by NGS for EGFR Mutated Lung Adenocarcinoma Treated With Gefitinib in BENEFIT Study (CTONG 1405)

Journal of Thoracic Oncology

English

P2.04-17 Pre-Therapy Radiomic Features Can Distinguish Hyperprogression From Other Response Patterns to PD1/PD-L1 Inhibitors in NSCLC

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P1.13-21 Clinical Efficacy and Safety of Apatinib Combined With EGFR - TKIs in Advanced Non-Small Cell Lung Cancer With EGFR - TKIs Resistance

Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial

P1.12-16 Management of Elderly Small-Cell Lung Cancer Patients in a Romanian Tertiary Care Center

P3.07-07 Multidisciplinary Supportive Care Assessment in Lung Cancer – A Case Study Example

P2.01-44 Prognostic Value of TP53 Hot Exon Mutation in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Identification of a Novel MET Exon 14 Skipping Variant Coexistent With EGFR Mutation in Lung Adenocarcinoma Sensitive to Combined Treatment With Afatinib and Crizotinib

MS24.02 Legal Action Against the Tobacco Industry in Europe

P2.01-37 a Ph 1/2 Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) With Docetaxel in PTS With Previously Treated NSCLC

P2.01-101 Dynamic Monitoring of Gene Alterations With ctDNA by NGS for EGFR Mutated Lung Adenocarcinoma Treated With Gefitinib in BENEFIT Study (CTONG 1405)

P2.04-17 Pre-Therapy Radiomic Features Can Distinguish Hyperprogression From Other Response Patterns to PD1/PD-L1 Inhibitors in NSCLC